CRDF
Cardiff Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.89
−2.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 198.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.61x
- Price / sales
- 136.23x
- Price / cash flow
- -1.69x
Enterprise value
- Enterprise value
- $35.1M
- EV / sales
- 69.18x
- EV / EBITDA
- -0.90x
- EV / EBIT
- -0.83x
- Market cap
- $69.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026